AbCellera Biologics Inc.ABCLNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank57
3Y CAGR-43.6%
5Y CAGR-18.3%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
-43.6%/yr
vs +162.5%/yr prior
5Y CAGR
-18.3%/yr
Recent deceleration
Acceleration
-206.1pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$75.13M+160.6%
2024$28.83M-24.2%
2023$38.02M-90.9%
2022$418.99M+27.1%
2021$329.69M+60.0%
2020$206.01M+1674.1%
2019$11.61M+31.5%
2018$8.83M-